Stockreport

Cardiff Oncology Full Year 2024 Earnings: Beats Expectations [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF US$0.95 loss per share (further deteriorated from US$0.93 loss in FY 2023). NasdaqCM:CRDF Earnings and Revenue History March 1st 2025 All figures shown in the chart [Read more]